Table 1. Regulated transcription factors during in vitro organogenesis.
| Gene family | No. | Percentage | W1 vs W0 | W2 vs W0 | W3 vs W0 | W4 vs W0 | ||||
| Up | Down | Up | Down | Up | Down | Up | Down | |||
| zinc finger | 48 | 19.4% | 6 | 18 | 2 | 11 | 13 | 25 | 14 | 20 |
| C2H2* | 12 | 4.8% | 1 | 5 | 1 | 1 | 2 | 7 | 2 | 6 |
| TAZ* | 11 | 4.4% | 1 | 4 | 3 | 3 | 6 | 3 | 4 | |
| Dof* | 10 | 4.0% | 3 | 1 | 2 | 2 | 5 | 2 | 3 | |
| CO-like* | 10 | 4.0% | 1 | 4 | 1 | 4 | 6 | 4 | 6 | 4 |
| C3H* | 2 | 0.8% | 2 | 2 | 2 | |||||
| PHD* | 2 | 0.8% | 1 | 1 | ||||||
| GATA* | 1 | 0.4% | 1 | 1 | 1 | 1 | ||||
| MYB | 32 | 12.9% | 13 | 8 | 4 | 7 | 13 | 8 | 16 | 8 |
| AP2/ERF | 26 | 10.5% | 2 | 10 | 2 | 11 | 7 | 17 | 7 | 13 |
| bHLH | 21 | 8.5% | 3 | 8 | 6 | 7 | 13 | 7 | 9 | |
| HB | 16 | 6.5% | 3 | 2 | 3 | 13 | 2 | 6 | ||
| WRKY | 12 | 4.8% | 5 | 2 | 2 | 9 | 3 | 5 | ||
| NAC | 11 | 4.4% | 1 | 5 | 5 | 3 | 6 | 2 | 6 | |
| bZIP | 9 | 3.6% | 3 | 1 | 6 | 2 | 5 | 1 | ||
| GRAS | 9 | 3.6% | 1 | 6 | 2 | 8 | 1 | 3 | ||
| ARF | 8 | 3.2% | 1 | 3 | 2 | 1 | 5 | 1 | 4 | |
| MADS | 8 | 3.2% | 2 | 1 | 4 | 2 | 5 | 2 | ||
| AUX/IAA | 6 | 2.4% | 2 | 1 | 6 | 2 | ||||
| LBD | 5 | 2.0% | 3 | 3 | 1 | 3 | 2 | 3 | 1 | |
| ABI3 | 4 | 1.6% | 2 | 1 | 1 | 1 | ||||
| LUG | 3 | 1.2% | 1 | 2 | 1 | |||||
| SET | 3 | 1.2% | 3 | 2 | 1 | |||||
| HSF | 3 | 1.2% | 1 | 1 | 1 | 2 | 1 | 2 | 1 | |
| CAMTA | 3 | 1.2% | 1 | 3 | 3 | |||||
| GRF | 3 | 1.2% | 3 | |||||||
| Trihelix | 3 | 1.2% | 1 | 2 | 1 | 1 | ||||
| TCP | 2 | 0.8% | 1 | 1 | 1 | |||||
| JUMONJI | 2 | 0.8% | 2 | 2 | 2 | |||||
| E2F | 2 | 0.8% | 2 | |||||||
| HMG | 2 | 0.8% | 1 | 1 | 2 | |||||
| LIM | 2 | 0.8% | 1 | 1 | 1 | 1 | ||||
| CCAAT | 1 | 0.4% | 1 | |||||||
| TLP | 1 | 0.4% | 1 | 1 | 1 | |||||
| FHA | 1 | 0.4% | 1 | |||||||
| PLATZ | 1 | 0.4% | 1 | |||||||
| Nin-like | 1 | 0.4% | 1 | |||||||
| Total | 248 | 100% | 45 | 79 | 12 | 51 | 73 | 126 | 80 | 89 |
*Subgroup of zinc finger family.